Header Logo

Connection

Anand Srinivasan to Imatinib Mesylate

Back to Details
This is a "connection" page, showing publications Anand Srinivasan has written about Imatinib Mesylate.
Anand Srinivasan
Connection Strength
0.656
Imatinib Mesylate
  1. Myeloid Neoplasm With Eosinophilia and FIP1L1-PDGFRA Rearrangement Treated With Imatinib Mesylate: A Pediatric Case With Long-term Follow-up. J Pediatr Hematol Oncol. 2019 May; 41(4):334-335.
    View in: PubMed
    Score: 0.656
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.